This page provides references to publications by ViaCyte staff and other experts in the fields of stem cell engineering, cell encapsulation and islet transplantation.

• Kelly et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nature Biotechnology (2011), 29: 750-756.
• McCall et al. Are stem cells a cure for diabetes? Clinical Science (2010), 118: 87-97.
• Emmanuel E. Baetge. Production of β-cells from human embryonic stem cells. Diabetes, Obesity and Metabolism (2008), 10: 186-194.
• Kroon et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cell in vivo. Nature Biotechnology (2008), 26: 443-452.
• McLean et al. Activin A efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells (2007), 25: 29-38.
• D’Amour et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology (2006), 24: 1392-1401.
• Didier Stainier. No stem cell is an islet (yet). The New England Journal of Medicine (2006), 354: 521-523.
• Madsen and Serup. Towards cell therapy for diabetes. Nature Biotechnology (2006), 24: 1481-1483.
• D’Amour et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnology (2005), 23: 1534-1541.
• Hoffman and Carpenter. Characterization and culture of human embryonic stem cells. Nature Biotechnology (2005), 23: 699-708.